Search by Drug Name or NDC
NDC 67544-0149-70 Mucinex 600 mg/1 Details
Mucinex 600 mg/1
Mucinex is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 67544-0149-70Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 67544-0149 |
---|---|
Product ID | 67544-149_cc734890-e42c-454a-b771-3ecd169d161a |
Associated GPIs | 43200010007420 |
GCN Sequence Number | 071885 |
GCN Sequence Number Description | guaifenesin TAB ER 12H 600 MG ORAL |
HIC3 | B3J |
HIC3 Description | EXPECTORANTS |
GCN | 35905 |
HICL Sequence Number | 000271 |
HICL Sequence Number Description | GUAIFENESIN |
Brand/Generic | Generic |
Proprietary Name | Mucinex |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 600 |
Active Ingredient Units | mg/1 |
Substance Name | GUAIFENESIN |
Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021282 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 67544-0149-70 (67544014970)
NDC Package Code | 67544-149-70 |
---|---|
Billing NDC | 67544014970 |
Package | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (67544-149-70) |
Marketing Start Date | 2012-08-22 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 1c84bf00-ebaa-4e69-a2c6-716631d209d9 Details
Uses
Warnings
Ask a doctor before use if you have
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- cough accompanied by too much phlegm (mucus)
Directions
Other information
Inactive ingredients
Repackaging Information
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma - TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
Count | 600 mg |
60 | 67544-149-53 |
120 | 67544-149-70 |
180 | 67544-149-80 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20171218DKJ
INGREDIENTS AND APPEARANCE
MUCINEX
guaifenesin tablet, extended release |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Labeler - Aphena Pharma Solutions - Tennessee, LLC (128385585) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aphena Pharma Solutions - Tennessee, LLC | 128385585 | REPACK(67544-149) |